In murine models of melanoma as well as lung and ovarian cancers, tumor-associated DCs exhibited an increased expression of the suppressor of cytokine signaling-3 (SOCS3), which suppressed the activity of the pyruvate kinase M2 (PKM2) enzyme responsible for catalyzing the final step of glycolysis. Here, SOCS3 is linked to ovarian cancer.